Impurity reference standards
Avanafil impurities & reference standards
Characterised Avanafil impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
28reference materials
COAHPLC · NMR · MS on request
(1S,2R,5S)-2-Isopropyl-5-methylcyclohexanecarboxylicacid
- CAS
- 62309-29-9
- Formula
- C11H20O2
- MW
- 184.27 g/mol
VQ-032955
(3,5-Dichloro-4-methoxyphenyl)methanamine Hydrochloride
- CAS
- 38057-59-9
- Formula
- C8H10Cl3NO
- MW
- 242.5 g/mol
VQ-029290
![(5-PyriMidinecarboxylicacid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-(Methylthio)-,ethyl ester) chemical structure](/media/structures/WLOQDGSMJNYRRC-UHFFFAOYSA-N.svg)
(5-PyriMidinecarboxylicacid, 4-[[(3-chloro-4-Methoxyphenyl)Methyl]aMino]-2-(Methylthio)-,ethyl ester)
- CAS
- 330785-81-4
- Formula
- C16H18ClN3O3S
- MW
- 367.9 g/mol
VQ-045253
(R)-2-(2-(Hydroxymethyl)pyrrolidin-1-yl)-4-((4-methoxybenzyl)amino)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
- CAS
- 2250242-21-6
- Formula
- C23H27N7O3
- MW
- 449.5 g/mol
VQ-043986
(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic Acid
- CAS
- 330785-84-7
- Formula
- C18H21ClN4O4
- MW
- 392.8 g/mol
VQ-024436
(S)-4-((3,5-Dichloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylic acid
- CAS
- 1643811-26-0
- Formula
- C18H20Cl2N4O4
- MW
- 427.3 g/mol
VQ-043987
(S)-Ethyl 4-(3-chloro-4-methoxybenzylamino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)pyrimidine-5-carboxylate
- CAS
- 330785-83-6
- Formula
- C20H25ClN4O4
- MW
- 420.9 g/mol
VQ-043872
4-((3-Chloro-4-methoxybenzyl)amino)-2-(methylsulfinyl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide
- CAS
- 1364671-52-2
- Formula
- C19H19ClN6O3S
- MW
- 446.9 g/mol
VQ-035143
4-((3-Chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylic Acid
- CAS
- 330786-34-0
- Formula
- C14H14ClN3O3S
- MW
- 339.8 g/mol
VQ-043061
Ethyl 4-((2-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate
- CAS
- 2520114-23-0
- Formula
- C16H18ClN3O3S
- MW
- 367.9 g/mol
VQ-035067
Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylsulfinyl)pyrimidine-5-carboxylate
- CAS
- 330785-82-5
- Formula
- C16H18ClN3O4S
- MW
- 383.9 g/mol
VQ-029291
Ethyl 4-((3-chloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate
- CAS
- 330785-99-4
- Formula
- C15H16ClN3O4
- MW
- 337.76 g/mol
VQ-043789
Ethyl 4-((3,5-dichloro-4-methoxybenzyl)amino)-2-(methylthio)pyrimidine-5-carboxylate
- CAS
- 2250242-48-7
- Formula
- C16H17Cl2N3O3S
- MW
- 402.3 g/mol
VQ-043751
FAQs — Avanafil impurities
Which Avanafil impurities do you supply?
We list 28 Avanafil-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Avanafil impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Avanafil impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Avanafil impurity standards
We reply within one business day with price, pack options, lead time and documentation.